[Forschungsbericht]Der Markt für Bauchspeicheldrüsenkrebstherapien wird bis 2025 voraussichtlich 4056,4 Millionen US-Dollar erreichen, verglichen mit 2011,2 Millionen US-Dollar im Jahr 2017; Es wird geschätzt, dass er von 2018 bis 2025 mit einer jährlichen Wachstumsrate von 8,1 % wächst. Bauchspeicheldrüsenkrebs entsteht, wenn die Zellen in der Bauchspeicheldrüse unkontrolliert wachsen. Basierend auf der Art der betroffenen Zellen kann Bauchspeicheldrüsenkrebs in zwei Typen eingeteilt werden: exokrine Tumoren und endokrine Tumoren. Diese Tumoren verhalten sich unterschiedlich. Daher werden sie unterschiedlich behandelt. Bauchspeicheldrüsenkrebs wird im Allgemeinen erst in einem späteren Stadium diagnostiziert, da die Symptome nicht leicht zu erkennen oder zu diagnostizieren sind. Faktoren wie eine chronische Entzündung der Bauchspeicheldrüse (Pankreatitis), Diabetes, Rauchen und Fettleibigkeit sind einige der identifizierten Ursachen für Bauchspeicheldrüsenkrebs. Das Wachstum des Marktes für Bauchspeicheldrüsenkrebstherapien wird auf Faktoren wie die steigende Zahl von Patienten mit Bauchspeicheldrüsenkrebs, steigende Gesundheitsausgaben für Bauchspeicheldrüsenmedikamente und die zunehmende Zahl der auf den Markt gebrachten Therapien zurückgeführt. Darüber hinaus wird erwartet, dass die Entwicklung einer effizienten Therapie zur Behandlung von Bauchspeicheldrüsenkrebs den Markt im Prognosezeitraum ankurbeln wird. Es wird jedoch erwartet, dass die Nebenwirkungen der Therapien und die geringe Erfolgsquote der Behandlungen den Markt für die Therapie von Bauchspeicheldrüsenkrebs bremsen werden.
Lukrative regionale Märkte für die Therapie von Bauchspeicheldrüsenkrebs
Markteinblicke
Anstieg der Zahl der Patienten, die an Bauchspeicheldrüsenkrebs leiden
Bauchspeicheldrüsenkrebs ist eine der aggressiven Krebsarten, die im Gewebe der Bauchspeicheldrüse entstehen und sich schnell auf die umliegenden Organe ausbreiten. Bauchspeicheldrüsenkrebs ist die zwölfthäufigste Krebserkrankung weltweit. Nach Angaben der American Cancer Society wird im Jahr 2018 in den USA voraussichtlich bei etwa 55.440 Patienten Bauchspeicheldrüsenkrebs diagnostiziert. Darüber hinaus berichtet die ACS auch, dass Bauchspeicheldrüsenkrebs die dritthäufigste krebsbedingte Todesursache in den USA ist und dies voraussichtlich auch der Fall sein wird Laut Cancer Research UK wurden im Jahr 2015 im Vereinigten Königreich etwa 9.921 neue Fälle von Bauchspeicheldrüsenkrebs diagnostiziert, während 8.912 Patienten an derselben Krebserkrankung starben. Der Krebs verläuft fast immer tödlich und erfordert daher mögliche Therapien für die Patienten. Behandlung. Beispielsweise geht die American Cancer Society davon aus, dass Bauchspeicheldrüsenkrebs für etwa 3 % aller Krebstodesfälle in den USA verantwortlich ist. Nach Angaben des National Institute of Health lebten im Jahr 2015 in den USA schätzungsweise 68.615 Patienten mit Bauchspeicheldrüsenkrebs. Es wird erwartet, dass die zunehmende Inzidenz und Prävalenz von Bauchspeicheldrüsenkrebs die Nachfrage nach Medikamenten, Therapien und Behandlungen der Patienten erhöhen wird. Darüber hinaus führen die steigenden Patientenzahlen zu Fortschritten in der Molekularbiologie und der chemischen Arzneimittelformulierung. Es wird daher erwartet, dass ein riesiger Pool von Patienten mit Bauchspeicheldrüsenkrebs das Wachstum des globalen Marktes für Bauchspeicheldrüsenkrebstherapien in den prognostizierten Jahren steigern wird.
Typ-Einblicke
Basierend auf dem Typ Der Markt für die Therapie von Bauchspeicheldrüsenkrebs ist in endokrinen Bauchspeicheldrüsenkrebs und exokrinen Bauchspeicheldrüsenkrebs unterteilt. Im Jahr 2017 hatte das Segment exokriner Bauchspeicheldrüsenkrebs nach Art den größten Marktanteil. Es wird erwartet, dass das Segment des exokrinen Bauchspeicheldrüsenkrebses in den kommenden Jahren am schnellsten wachsen wird, da diese Krebsart die häufigste und am häufigsten auftretende Krebsart ist und daher in den prognostizierten Jahren voraussichtlich einen riesigen Patientenpool haben wird.
Globaler Markt für Bauchspeicheldrüsenkrebstherapie nach Typ 2017 und 2025
Therapieeinblicke
Basierend auf der Therapie ist der Markt für Bauchspeicheldrüsenkrebstherapie in biologische Therapie, Chemotherapie und andere unterteilt. Im Jahr 2017 hielt das Segment der biologischen Therapie nach Therapie den größten Marktanteil. Darüber hinaus wird erwartet, dass das Segment der biologischen Therapien in den kommenden Jahren am schnellsten wachsen wird, da die Zahl der neuen Immuntherapien sowie der gezielten Zelltherapie, die den Krebs ohne schwerwiegende Nebenwirkungen behandelt und zahlreiche therapeutische Vorteile gegenüber der herkömmlichen Therapie bietet, zunimmt Chemotherapien.
Strategische Einblicke
Bio-Strategien sind die am häufigsten von Unternehmen auf dem Markt für Bauchspeicheldrüsenkrebs-Therapien angewandten Strategien, die es ihnen ermöglichen, ihre globale Präsenz sowie ihr Produkt- und Serviceportfolio zu erweitern. Die Marktteilnehmer haben auch organische Strategien wie Produktzulassungen, klinische Studien und andere Strategien übernommen, die es ihnen ermöglicht haben, ihren globalen Kundenstamm zu vergrößern, was ihnen auch ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten.
Globale Bauchspeicheldrüsenkrebstherapie Markt nach Typ
- Exokriner Bauchspeicheldrüsenkrebs
- Endokriner Bauchspeicheldrüsenkrebs
Globaler Markt für Bauchspeicheldrüsenkrebstherapie nach Therapie
- Biologische Therapie
- Chemotherapie
- Andere
Globaler Markt für Bauchspeicheldrüsenkrebs-Therapie nach Geographie
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
- Italien
- Großbritannien
- Spanien
- Asien-Pazifik (APAC)
- China
- Indien
- Südkorea
- Japan
- Australien
- Naher Osten und Afrika (MEA)
- Südafrika
- Saudi-Arabien
- VAE
- Süd- und Mittelamerika
- Brasilien
- Argentinien
Firmenprofile
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Amgen Inc
- Novartis AG
- Celgene Corporation
- Merck & Co., Inc
- Clovis Oncology
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc
< li>Pharmacyte Biotech Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Eli Lilly and Company
2. F. Hoffmann-La Roche AG
3. Celgene Corporation
4. Amgen Inc.
5. Novartis AG
6. Pharmacyte Biotech Inc.
7. Clovis Oncology
8. Teva Pharmaceutical Industries Ltd.
9. Pfizer Inc.
10. Merck & Co., Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2018
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2018
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2018
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2018
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2018
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2018
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2018
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2018
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)